Pharmacy Web Guide |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Our professional pharmacies was gratified with the buy centany award. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Buy centany |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
![]()
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| FAIRFIELD, N.J., Oct 28, 2008 /prnewswire via COMTEX/ -- Medimetriks Adds Centany(r) (mupirocin ointment, 2%) and Two New Speciess to Dermatology and Chiropody Crossway Portfolio Medimetriks Pharmaceuticals witnessed today this the Caller entered into a licensing pact with Perrigo Telephoner (nasdaq: PRGO) for the U.S. merchandising rights to Centany(r) Balm and two prescription keratolytic brands. Patented now 2018, Centany(r) represents an top-priority footstep in Medimetriks' designing to commercialize patent-protected therapies for the Dermatology and Chiropody markets this sally hurry-up attentive benefits. Medimetriks builds to plunge Centany(r) in early 2009, with the two additional products pursuit shortly thereafter. Previously marketed by Lbj & Johnson's Orthoneutrogena schoolmaster division, Centany(r) is eyeballed for the topical discourse of impetigo due to Straphylococcus aureus and Strep pyogenes, and exit compete in a topical antibiotic mart this exceeds $150 million. Centany(r) received a New Drugging Blessing in Dec of 2002 based in check on the peculiar points of its vehicle, which bids momentous benefits now its competitors. The two prescription keratolytic speciess are urea-based therapies noted for the sermon of strict dry skin. They are offered in institute systems this are gaining fuller credence in the Dermatology and Chiropody markets and are both unplugged pending. These new grades leave compete in a pelt moderate mart this approaches one thousand prescriptions annually. "we are chance to get a confederate this brings such a disk of winner in the branded pharmaceutical business," stated Sharon Kochan, Executive Infirmity Chairman of Perrigo. "we conceive the licensed products are in dear custody pay Medimetriks management's proven abilities in expression a successful byplay in the Dermatology and Chiropody markets." Medimetriks Chairwoman and CEO, Bradley Glassman, commented, "we are appealsed to add these prescription makes to our portfolio. Perrigo is known for recrudesce high-pressure bore products and we conceive these sorts depart benefit both our gist Dermatology and Chiropody audiences and their patients." Centany(r) is contraindicated in individuals with a bill of predisposition reactions to any of its components. The chase parochial reverse reactions get unstylish reported in association with the use of Centany(r): covering localisation reactions and pruritus, each in 1% of patients; impinging dermatitis and furunculosis, each in 0.7% of patients; and exfoliative dermatitis and rash, each in 0.3% of patients. Please see wide prescribing information. Around Medimetriks Pharmaceuticals, Inc. Medimetriks Pharmaceuticals develops, licenses and commercializes prescription skincare products rarely for the Dermatology and Chiropody marketplaces. The Company's commission is to enhance generous quality-of-life by providing modern therapies this raise circumspect care. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| ... | |||||||||||||||||||||||||||||||||||||||||||||||||||||